Navigation Links
Optimer Pharmaceuticals Appoints Gregory Papaz to New Position of Senior Vice President of Commercial Operations
Date:12/20/2010

SAN DIEGO, Dec. 20, 2010 /PRNewswire-FirstCall/ -- Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) today announced that Gregory Papaz has joined Optimer as Senior Vice President of Commercial Operations.  Mr. Papaz will lead the preparations for the planned commercialization of fidaxomicin.  He brings with him more than thirty years of experience in the healthcare and pharmaceutical industry managing pharmaceutical sales teams.

(Logo:  http://photos.prnewswire.com/prnh/20090413/LA97352LOGO)

"Greg comes to Optimer with best-in-class business experience in the hospital and specialty market segments combined with a proven record of recent successful new product introductions," said Pedro Lichtinger, Optimer's President and CEO. "Greg will build and lead our commercial organization in the United States and is ideally suited to lead a successful hospital launch for fidaxomicin."

Prior to joining Optimer, Mr. Papaz held the position of Rheumatology Sales Director, Commercial Marketing at Genentech where he was responsible for planning and launching Actemra®, a drug for rheumatoid arthritis. In this role, Mr. Papaz staffed a 130-person sales team which sold directly into hospitals, with direct contact to hospital pharmacies, physician leaders and hospital management. Prior to Genentech, he worked for Roche Pharma as the Anemia National Sales Director. Prior to Roche Pharma, Mr. Papaz was the Vice President, Cardiovascular Hospital Sales at Sanofi-Aventis.  While in this position, Greg merged and restructured the Sanofi hospital team with the Aventis Advanced Therapeutics team.  This resulted in the creation of the largest specialized sales force at Sanofi, as well as the largest hospital sales force in the U.S. pharma industry.  Consequently, Greg was involved in overs
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Optimer Pharmaceuticals to Host Investor and Analyst Event on November 18
2. Optimer Pharmaceuticals Announces Combined Data From Fidaxomicin Phase 3 Trials for the Treatment of Clostridium difficile Infection (CDI) Presented at IDSA
3. Optimer Pharmaceuticals Announces Presentations of Additional Fidaxomicin Phase 3 Data at Upcoming ICAAC Annual Meeting
4. Optimer Pharmaceuticals to Present at September 2010 Investor Conferences
5. Optimer Pharmaceuticals Fidaxomicin Marketing Authorization Application Accepted for Review by European Medicines Agency
6. Optimer Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference
7. Optimer Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference
8. Optimer Announces Presentation of Additional Data From Fidaxomicin Phase 3 Study for the Treatment of Clostridium Difficile Infection (CDI)
9. Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
10. Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection
11. Optimer Pharmaceuticals Receives Production Patent for Lead Product Candidate Fidaxomicin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)...  Semler Scientific, Inc. (Nasdaq: SMLR ), a ... insurers and physician groups, today reported financial results for ... "In the second quarter of 2015, Semler reported ... 54%, quarter over quarter revenue growth of 8%, and ... FloChec® units of 18%," said Doug Murphy-Chutorian, M.D., chief ...
(Date:7/30/2015)... 30, 2015 Edwards Lifesciences Corporation (NYSE: EW ... and hemodynamic monitoring, today announced that Robert A. Ingram ... "Bob is an ardent champion for innovation in the ... have him on Edwards, board as we pursue our focused ... and CEO.  "Bob has provided a valuable perspective to our ...
(Date:7/30/2015)...  Tandem Diabetes Care®, Inc. (NASDAQ: TNDM ... the t:slim® and t:flex™ Insulin Pumps, today announced ... with Dexcom, Inc. to allow the integration of ... G5 and G6 continuous glucose monitoring ("CGM") systems. ... with Dexcom,s future CGM systems is an important ...
Breaking Medicine Technology:Semler Reports Second Quarter 2015 Financial Results 2Semler Reports Second Quarter 2015 Financial Results 3Semler Reports Second Quarter 2015 Financial Results 4Semler Reports Second Quarter 2015 Financial Results 5Semler Reports Second Quarter 2015 Financial Results 6Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 3
... FDA Regarding Possible Phase III Trial Based on Human Data ... ... Neupogen(R), RICHMOND, Va., July 10, 2008 Insmed Inc.,(Nasdaq: ... medical needs, today announced that it has demonstrated the,bioequivalence of INS-19, ...
... Sosei Group Corporation,("Sosei"; TSE Mothers Index: 4565), ... Japanese Phase III clinical trial for the,emergency contraceptive ... rights to the product in Japan from HRA ... evaluate the safety and prevented,pregnancy rate of SOH-075 ...
Cached Medicine Technology:Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company 2Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company 3Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company 4Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company 5Sosei Announces Completion of Phase III Trial for NorLevo(R) 2
(Date:8/3/2015)... ... August 03, 2015 , ... Foot and Ankle Specialists ... associate podiatrist, creating the largest medical practice in the Mid-Atlantic region – and the ... operates 21 locations with 33 doctors. , Dr. Hetal Kathrotiya-Mago is a Maryland native. ...
(Date:8/2/2015)... ... August 03, 2015 , ... ... attending and exhibiting at the Association for Healthcare Documentation Integrity’s (AHDI) conference being ... are pleased for the opportunity the AHDI conference provides us to interact with ...
(Date:8/1/2015)... ... 02, 2015 , ... AlignLife Office Coordinator Heather Pugh earned the ... for patients at this natural health care center in Winamac. , "Oftentimes patients are ... "Heather's role is vital to our approach because we want to focus on the ...
(Date:8/1/2015)... ... August 01, 2015 , ... Calvary Hospital today announced that it ... Bronx campus. The goal is to bring this Torah – dating from 1880 – ... rituals and religious services. , Scroll No. 515, from the town of Taus-Domazlice, ...
(Date:8/1/2015)... ... August 01, 2015 , ... Lume Wellness creators Alex, Robert, and Sam have ... the Apple AppStore. , The app is designed to track various metrics of ... tool to view personal health and use this information for positive behavior modification. Lume ...
Breaking Medicine News(10 mins):Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 2Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 3Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 4Health News:Career Step to Exhibit at AHDI Conference in Alexandria, Virginia on August 7-8 2Health News:New Patient Advocate Enhances Natural Health Care 2Health News:Calvary Hospital Announces Plans to Restore Historic Torah 2Health News:Calvary Hospital Announces Plans to Restore Historic Torah 3Health News:Lume Wellness Launches Health and Fitness Tracker iPhone App 2
... Three-day Symposium Focuses on Improving Drought Tolerance, ... around the world convened here today for a ... in plants. Hosted by DuPont,(NYSE: DD ) ... to share,research information among public and private organizations ...
... Eight Consecutive ... Quarters, According to MD Buyline, NASHUA, N.H., Feb. 4 ... (CAD),solutions for the early identification of cancer, today announced that ... to,the independent healthcare research group MD Buyline., In its ...
... Feb. 4 The Providence Service,Corporation (Nasdaq: ... Chief Executive Officer, is scheduled to present an ... Healthcare Services Conference on,Monday, February 11, 2008 at ... Providence,s presentation is scheduled for 12:00 p.m. EST. ...
... pain scores by more than 78% , , MONDAY, Feb. 4 ... medicine go down, a new study shows it may also ... that a simple sugar-and-water solution will also ease parents, fears ... will encourage parents to get their children vaccinated," said study ...
... New Proprietary Technology to Create Healthier and ... Higher Value ... world leader in stabilized rice bran (SRB), nutrient research and,technology, announced ... rice bran oil processing facility in South America,located in Brazil. This ...
... JUAN, Puerto Rico, Feb. 4 Triple-S,Management Corporation (NYSE: ... and Chief Executive Officer, and Juan-Jose Roman,Finance Vice President ... analysts at the UBS Global Healthcare Conference in,New York ... time. The,presentation will be broadcast live through the Internet ...
Cached Medicine News:Health News:DuPont Hosts Meeting of Leading Plant Scientists to Improve World Agricultural Productivity 2Health News:iCAD Ranks #1 in Mammography CAD User Satisfaction 2Health News:iCAD Ranks #1 in Mammography CAD User Satisfaction 3Health News:Providence Service Corporation to Present at the 2008 UBS Global Healthcare Services Conference on February 11 2Health News:Sugar Water Eases Pain of Infant Vaccinations 2Health News:Sugar Water Eases Pain of Infant Vaccinations 3Health News:NutraCea to Purchase Largest Rice Bran Oil Processing Facility in South America 2Health News:NutraCea to Purchase Largest Rice Bran Oil Processing Facility in South America 3Health News:NutraCea to Purchase Largest Rice Bran Oil Processing Facility in South America 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: